NVWM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.82K Sell
9
-116
-93% -$87.7K ﹤0.01% 412
2026
Q2
$77.9K Sell
125
-3
-2% -$2.04K 0.02% 217
2026
Q1
$98.9K Hold
128
– – 0.02% 219
2025
Q4
$98.8K Buy
128
+122
+2,033% +$82.9K 0.02% 215
2025
Q3
$3.37K Hold
6
– – ﹤0.01% 371
2025
Q2
$3.15K Hold
6
– – ﹤0.01% 371
2025
Q1
$3.81K Buy
6
+3
+100% +$2.06K ﹤0.01% 336
2024
Q4
$2.14K Sell
3
-985
-100% -$827K ﹤0.01% 371
2024
Q3
$1.04M Buy
988
+14
+1% +$15.6K 0.26% 122
2024
Q2
$1.02M Sell
974
-5
-0.5% -$4.85K 0.27% 114
2024
Q1
$942K Buy
979
+84
+9% +$79.9K 0.26% 124
2023
Q4
$786K Buy
+895
New +$737K 0.24% 134
2023
Q2
– Sell
-13
Closed -$10.7K – 478
2023
Q1
$10.7K Hold
13
– – ﹤0.01% 337
2022
Q4
$9.38K Hold
13
– – ﹤0.01% 327
2022
Q3
$9K Hold
13
– – ﹤0.01% 336
2022
Q2
$8K Hold
13
– – ﹤0.01% 363
2022
Q1
$9K Hold
13
– – ﹤0.01% 389
2021
Q4
$8K Buy
13
+6
+86% +$3.69K ﹤0.01% 411
2021
Q3
$4K Buy
+7
New +$4.35K ﹤0.01% 440
2020
Q4
– Sell
-1,064
Closed -$596K – 426
2020
Q3
$596K Buy
1,064
+43
+4% +$26.1K 0.28% 110
2020
Q2
$637K Buy
1,021
+2
+0.2% +$1.14K 0.34% 91
2020
Q1
$498K Buy
+1,019
New +$420K 0.35% 84
2019
Q2
– Sell
-1,052
Closed -$432K – 382
2019
Q1
$432K Buy
+1,052
New +$433K 0.29% 115

Other funds holding REGN

NVWM LLC's REGN Position: Q3 2026 in Review

NVWM LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 93% in Q3 2026, selling an estimated $87.7K and leaving 9 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

NVWM LLC first reported a position in REGN in Q1 2019 and has held it in 23 quarters since. The position peaked at $1.04M in Q3 2024. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • NVWM LLC held 9 shares of Regeneron Pharmaceuticals worth $6.82K as of Q3 2026.
  • NVWM LLC sold 116 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $87.7K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #412 holding.
  • NVWM LLC first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 23 quarters since.
  • NVWM LLC's Regeneron Pharmaceuticals position peaked at $1.04M in Q3 2024.
  • 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.